RI
TEVA icon

Ridgewood Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Ridgewood Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,500
Closed -$11.3K – 698
2023
Q2 		$11.3K Hold
1,500
– – 0.01% 499
2023
Q1 		$13.3K Buy
+1,500
New +$14.8K 0.01% 490
2018
Q2 		– Sell
-13,211
Closed -$226K – 159
2018
Q1 		$226K Sell
13,211
-108
-0.8% -$2.11K 0.21% 133
2017
Q4 		$252K Sell
13,319
-15
-0.1% -$226 0.23% 127
2017
Q3 		$235K Buy
13,334
+4,497
+51% +$101K 0.22% 125
2017
Q2 		$294K Buy
8,837
+774
+10% +$24K 0.29% 103
2017
Q1 		$259K Buy
8,063
+1,007
+14% +$34.4K 0.28% 102
2016
Q4 		$255K Buy
+7,056
New +$282K 0.3% 92

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Ridgewood Investments's TEVA Position: Q3 2023 in Review

Ridgewood Investments sold out of Teva Pharmaceuticals (TEVA) in Q3 2023, closing a stake of 1,500 shares — an estimated $11.3K sold.

Ridgewood Investments first reported a position in TEVA in Q4 2016 and held it in 8 quarters. The position peaked at $294K in Q2 2017. 435 funds tracked by Wall St. Rank hold TEVA as of Q3 2023.

  • Ridgewood Investments reported no remaining Teva Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Ridgewood Investments sold 1,500 Teva Pharmaceuticals shares in Q3 2023, an estimated $11.3K.
  • Ridgewood Investments first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 8 quarters.
  • Ridgewood Investments's Teva Pharmaceuticals position peaked at $294K in Q2 2017.
  • 435 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2023.

Based on Ridgewood Investments's 13F filing for Q3 2023, filed 20 Oct 2023.